Lowest-Rated Stocks Positive News Sentiment NYSE:FMS Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. $19.69 +0.34 (+1.76%) (As of 02/8/2023 12:00 AM ET) Add Compare Share Share Today's Range$19.61▼$19.9550-Day Range$15.47▼$19.3552-Week Range$12.78▼$34.96Volume870,745 shsAverage Volume657,894 shsMarket Capitalization$11.54 billionP/E Ratio13.96Dividend Yield2.58%Price Target$35.96 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Fresenius Medical Care AG & Co. KGaA MarketRank™ ForecastAnalyst RatingHold1.78 Rating ScoreUpside/Downside82.6% Upside$35.96 Price TargetShort InterestHealthy0.25% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth-19.58%From $1.43 to $1.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.35 out of 5 starsMedical Sector216th out of 1,026 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry3rd out of 9 stocks 2.9 Analyst's Opinion Consensus RatingFresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 1.78, and is based on 1 buy rating, 5 hold ratings, and 3 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $35.96, Fresenius Medical Care AG & Co. KGaA has a forecasted upside of 82.6% from its current price of $19.69.Amount of Analyst CoverageFresenius Medical Care AG & Co. KGaA has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.25% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.Short Interest Ratio / Days to CoverFresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 15.62%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldFresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.58%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 42.61% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FMS. Previous Next 3.2 News and Social Media Coverage News SentimentFresenius Medical Care AG & Co. KGaA has a news sentiment score of 1.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.Search Interest1 people have searched for FMS on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 5.56% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fresenius Medical Care AG & Co. KGaA are expected to decrease by -19.58% in the coming year, from $1.43 to $1.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 149.64.Price to Earnings Ratio vs. SectorThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.65.Price to Book Value per Share RatioFresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) StockFresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America Segment, EMEA Segment, Asia-Pacific Segment and Latin America Segment. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.Read More Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FMS Stock News HeadlinesFebruary 2, 2023 | finance.yahoo.comCan Mixed Fundamentals Have A Negative Impact on Fresenius Medical Care AG & Co. KGaA (ETR:FME) Current Share Price Momentum?January 12, 2023 | finance.yahoo.comAre Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 46%?February 9, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,476%Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...January 5, 2023 | finance.yahoo.comFresenius Medical Care North America, IKONA Health Receive Major Grant to Expand Virtual Reality Healthcare Education, Improve Access in Rural MississippiDecember 29, 2022 | finance.yahoo.comFresenius Medical Care KGaA (ETR:FME) Will Be Hoping To Turn Its Returns On Capital AroundDecember 19, 2022 | markets.businessinsider.com2008® Series Hemodialysis Machine with New Tubing Released for Care DeliveryDecember 12, 2022 | finance.yahoo.comWhat Is Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Doing?December 6, 2022 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA: Fresenius Shares Remain Cheap While Changing CEOs and Awaiting Transformation PlanFebruary 9, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,476%Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...November 24, 2022 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA's (ETR:FME) top owners are individual investors with 38% stake, while36% is held by institutionsNovember 16, 2022 | finance.yahoo.comShould You Now Sell Fresenius Medical Care AG & Co. KGaA (FMS)?November 14, 2022 | finance.yahoo.com3 Stocks With Dividends of 3% or More to Buy on the DipNovember 2, 2022 | finance.yahoo.comFresenius Medical's (FMS) Q3 Earnings and Revenues TopNovember 1, 2022 | finance.yahoo.comFresenius Medical Care KGaA (ETR:FME) shareholders have endured a 64% loss from investing in the stock five years agoOctober 31, 2022 | finance.yahoo.comUPDATE 2-Fresenius cuts profit guidance again on slower recovery, rising costsOctober 31, 2022 | finance.yahoo.comFresenius Medical Shares Rise Despite FY Profit Estimate CutOctober 7, 2022 | finance.yahoo.com10 Best European Dividend Stocks to Buy NowSeptember 23, 2022 | seekingalpha.comFMS Fresenius Medical Care AG & Co. KGaASeptember 15, 2022 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA (FMS)September 12, 2022 | finance.yahoo.comFresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE AwardAugust 2, 2022 | finance.yahoo.comCytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care PlatformsAugust 2, 2022 | nasdaq.comFresenius Medical's (FMS) Q2 Earnings Miss, Revenues TopJuly 28, 2022 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA: After Tough Q2, Fresenius' Outlook Cut for 2022, Pulled for 2025; Shares Cheap Even After FVE CutJuly 27, 2022 | finance.yahoo.comFresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in DialysisJuly 4, 2022 | morningstar.comFresenius Medical Care AG & Co. KGaA ADR - Stock Valuation FMSJune 21, 2022 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA: Supreme Court Ruling Raises Uncertainty for DaVita and FreseniusJune 21, 2022 | morningstar.comFresenius Medical Care AG & Co. KGaA ADR - Stock AnalysisSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FMS Company Calendar Last Earnings11/02/2021Today2/08/2023Next Earnings (Estimated)2/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:FMS CUSIPN/A CIK1333141 Webwww.freseniusmedicalcare.com Phone(496) 172-6090Fax49-6172-609-2301Employees122,909Year Founded1912Price Target and Rating Average Stock Price Forecast$35.96 High Stock Price Forecast$72.00 Low Stock Price Forecast$11.70 Forecasted Upside/Downside+82.6%Consensus RatingHold Rating Score (0-4)1.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$1.41 Trailing P/E Ratio13.96 Forward P/E Ratio13.77 P/E GrowthN/ANet Income$1.15 billion Net Margins4.01% Pretax Margin6.95% Return on Equity6.03% Return on Assets2.55% Debt Debt-to-Equity Ratio0.48 Current Ratio1.34 Quick Ratio0.96 Sales & Book Value Annual Sales$20.85 billion Price / Sales0.55 Cash Flow$5.50 per share Price / Cash Flow3.58 Book Value$28.22 per share Price / Book0.70Miscellaneous Outstanding Shares586,050,000Free FloatN/AMarket Cap$11.54 billion OptionableOptionable Beta1.02 Social Links Key ExecutivesHelen GizaChief Executive & Financial OfficerFranklin W. MadduxGlobal Chief Medical OfficerDominik HegerSenior VP, Head-IR & Corporate CommunicationsWilliam ValleChief Executive Officer-North AmericaKatarzyna Mazur-HofsaessCEO-Europe, Middle East & AfricaKey Competitorsagilon healthNYSE:AGLDaVitaNYSE:DVASotera HealthNYSE:SHCProgynyNASDAQ:PGNYQiagenNYSE:QGENView All CompetitorsInsiders & InstitutionsWulff Hansen & CO.Bought 4,450 shares on 2/7/2023Ownership: 0.003%Envestnet Asset Management Inc.Sold 60,066 shares on 2/7/2023Ownership: 0.003%Pacer Advisors Inc.Bought 145,743 shares on 2/6/2023Ownership: 0.025%Pzena Investment Management LLCBought 11,209,015 shares on 2/3/2023Ownership: 4.152%Hardman Johnston Global Advisors LLCSold 682 shares on 2/3/2023Ownership: 0.007%View All Institutional Transactions FMS Stock - Frequently Asked Questions Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares. View FMS analyst ratings or view top-rated stocks. What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023? 9 equities research analysts have issued twelve-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $72.00. On average, they anticipate the company's stock price to reach $35.96 in the next year. This suggests a possible upside of 82.2% from the stock's current price. View analysts price targets for FMS or view top-rated stocks among Wall Street analysts. How have FMS shares performed in 2023? Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 on January 1st, 2023. Since then, FMS stock has increased by 20.8% and is now trading at $19.74. View the best growth stocks for 2023 here. Are investors shorting Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of December. As of December 30th, there was short interest totaling 1,280,000 shares, an increase of 14.3% from the December 15th total of 1,120,000 shares. Based on an average trading volume of 1,190,000 shares, the short-interest ratio is presently 1.1 days. View Fresenius Medical Care AG & Co. KGaA's Short Interest. When is Fresenius Medical Care AG & Co. KGaA's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023. View our FMS earnings forecast. How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.55 earnings per share for the quarter, hitting the consensus estimate of $0.55. The company earned $5.24 billion during the quarter, compared to analysts' expectations of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.01% and a trailing twelve-month return on equity of 6.03%. How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Stockholders of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date is Friday, May 13th. Read our dividend analysis for FMS. Is Fresenius Medical Care AG & Co. KGaA a good dividend stock? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.58%. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 42.61% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FMS. What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F). What is Fresenius Medical Care AG & Co. KGaA's stock symbol? Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS." Who are Fresenius Medical Care AG & Co. KGaA's major shareholders? Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (4.15%), Pacer Advisors Inc. (0.02%), Capricorn Fund Managers Ltd (0.02%), Crossmark Global Holdings Inc. (0.01%), First Heartland Consultants Inc. (0.01%) and Hardman Johnston Global Advisors LLC (0.01%). How do I buy shares of Fresenius Medical Care AG & Co. KGaA? Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Fresenius Medical Care AG & Co. KGaA's stock price today? One share of FMS stock can currently be purchased for approximately $19.74. How much money does Fresenius Medical Care AG & Co. KGaA make? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $11.57 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.41 on an earnings per share basis. How many employees does Fresenius Medical Care AG & Co. KGaA have? The company employs 122,909 workers across the globe. Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries? The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.Read More How can I contact Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301. This page (NYSE:FMS) was last updated on 2/9/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.